ABSTRACT: The genus Megalocytivirus in the family Iridoviridae encompasses isolates of red sea bream iridovirus (RSIV) and grouper sleepy disease iridovirus (GSDIV). In the present study, humpback grouper Cromileptes altivelis juveniles were challenged with GSDIV after vaccination with a commercial RSIV vaccine. The unvaccinated group (in duplicate) showed higher mortalities (59.3 to 66.7%) than the vaccination group (0% mortalitiy, in duplicate). Surviving fish in the vaccinated group displayed masses of enlarged cells in the spleen. Electron microscopy revealed that they contained hemosiderin granules within the cytoplasm. In contrast, moribund fish from the unvaccinated group exhibited large numbers of inclusion body-bearing cells (IBCs) in the spleen, while surviving fish displayed masses of enlarged cells in which a small number of GSDIV virions were assembled.
INTRODUCTION
The genus Megalocytivirus in the family Iridoviridae encompasses several viral isolates such as grouper sleepy disease iridovirus (GSDIV), red sea bream iridovirus (RSIV), sea bass iridovirus (SBIV), African lampeye iridovirus (ALIV), dwarf gourami iridovirus (DGIV), Taiwan grouper iridovirus (TGIV) and infectious spleen and kidney necrosis virus (ISKNV), which are genetically identical (Chinchar et al. 2005) . In Indonesia, groupers Epinephelus spp. are major mariculture fish species, and in recent years, with the rapidly developing aquaculture industries, viral diseases have caused severe epizootics resulting in mass mortalities and large-scale economic losses. GSDIV has caused mass mortality in orange-spotted grouper E. coioides cultured in pen-cages off North-Sumatra Island ) and orange-spotted grouper E. coioides and Bleeker's grouper E. bleekeri cultured in pens offshore of Bali Island ). GSDIV has also been shown to infect other groupers such as the humpback grouper Cromileptes altivelis (Mahardika et al. 2004) , tiger grouper E. fuscoguttatus and marbled grouper E. polyphekadion (K. Mahardika unpubl. data). In ornamental freshwater fishes, megalocytivirus has also been isolated from diseased African lampeye Aplocheilichthys normani, which were cultured on Sumatra Island and exported to Japan (Sudthongkong et al. 2002a) , and diseased dwarf gourami Colisa lalia, which were exported to Australia from southeast Asia (Go & Whittington 2006) . Moreover, megalocytivirus diseases have also been found in both marine and freshwater fishes in other Asian countries (Inouye et al. 1992 , Chua et al. 1994 , Matsuoka et al. 1996 , Danayadol et al. 1997 , Kasornchandra & Khongpradit 1997 , Chou et al. 1998 , Jung & Oh 2000 , Chao et al. 2002 , Sano et al. 2002 , Sudthongkong et al. 2002b , Weng et al. 2002 , Chen et al. 2003 , GibsonKueh et al. 2003 , Shi et al. 2004 . A diagnostic feature of megalocytivirus disease is the formation of inclusion body-bearing cells (IBCs) as well as necrotized cells, both of which are observed as enlarged cells by light microscopy (Miyazaki 2007) .
Recently, a commercialized formalin-inactivated RSIV vaccine has been shown to be highly efficient in protecting vaccinated red sea bream Pagrus major and other cultured marine fishes against RSIV disease (RSIVD) (Nakajima et al. 1997 . However, the ultrastructural features of fish vaccinated against megalocytivirus were not investigated.
In order to compare histopathological changes in unvaccinated, surviving fish after challenge with GSDIV with changes in surviving fish after being vaccinated and challenged with GSDIV, we undertook vaccination trials using a commercialized formalininactivated RSIV vaccine 'Biken' (The Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan). The present study describes the results of the vaccination test and ultrastructural features of the enlarged cells that developed in surviving fish of the vaccinated and unvaccinated groups.
MATERIALS AND METHODS
Experimental fish. For vaccination experiments, a total of 120 humpback grouper (mean body weight, 5 g) were obtained from a fish breeder in Bali Island. Ten samples of these were examined by PCR assay using a primer set for SJNNV (striped jack nervous necrosis virus) (Nishizawa et al. 1994 ) and for Pst I restriction fragment of RSIV genomic DNA (Kurita et al. 1998) , and all were negative for the presence of NNV (nervous necrosis virus: Betanodavirus) and megalocytivirus.
Virus stock. The GSDIV stock used in the experimental infections was derived from the spleens of tiger groupers that were experimentally infected with a spleen filtrate, which originated from orange-spotted groupers with grouper sleepy disease (GSD). The spleens were stored at -80°C after all of the spleen samples were confirmed positive for GSDIV by PCR ('PCR analysis'; see below). For the challenge tests the spleen tissue was homogenized in 10× vol of phosphatebuffered saline (PBS, pH 7.4) in a glass homogenizer. The homogenate was centrifuged at 3000 × g for 5 min at 4°C, and the supernatant was harvested and filtered (450 nm). To determine the appropriate challenge dose for the vaccination trials, a pilot experiment was conducted using 3 dilutions of this GSDIV preparation, injected intramuscularly (i.m.), 0.1 ml per fish, 5 fish per group.
Vaccination and challenge tests. One experiment was conducted with duplicate tanks (27 to 28 fish per tank) for each of the vaccinated and unvaccinated (control) groups. The vaccinated fish were injected (i.m.) with 0.1 ml of the formalin-inactivated RSIV vaccine 'Biken', according to the manufacturer's protocol. The unvaccinated fish were injected (i.m.) with the same amount of Eagle's minimum essential medium (EMEM) supplemented with 2% fetal bovine serum. The fish were held in tanks (200 l at 28 to 31°C) with aeration and daily water exchange. Ten days post-vaccination, all fish were challenged (i.m.) with 0.1 ml of a 10 -1 dilution of GSDIVpositive spleen filtrate and were monitored for 17 d. Moribund and dead fish were removed from the tanks, dissected and samples were processed for laboratory examination. At the end of the experiment, all surviving fish were dissected for subsequent laboratory examination. Tissue samples of 26 moribund fish, 16 surviving fish in the unvaccinated group and 27 surviving fish in the vaccinated group were fixed in Bouin's fluid (15 ml picric acid, 5 ml of 37% formaldehyde solution containing 8% methanol, 1 ml acetic acid) for histological examination. Further samples of the spleen tissue were fixed in 70% Karnovsky's solution (1.6 g paraformaldehyde in 20 ml distilled water, 2 ml of 70% glutaraldehyde, 35 ml of 0.2 M PBS, 13 ml distilled water), post-fixed in 1% OsO 4 and processed for examination by electron microscopy.
PCR analysis. PCR analysis to test for the presence of GSDIV in fish tissues was undertaken using primers 1-F (5'-CTCAAACACTCTGGCTCATC-3') and 1-R (5'-GCACCAACACATCTCCTATC-3'), which were derived from the DNA sequence of the 959-bp Pst I fragment of RSIV (Kurita et al. 1998) . Using this PCR test, amplification products of ca. 570 bp were generated. In adddition to the viral inoculum, the spleens of 10 surviving fish in the vaccinated group, and 10 dead and 10 surviving fish in the unvaccinated group, were processed for PCR analysis. DNA templates were extracted from ca. 10 mg of spleen tissue using ISOGEN (Wako Nippon Gene) according to the manufacturer's protocol. The PCR amplification was performed under conditions described previously by Kurita et al. (1998) .
RESULTS AND DISCUSSION
In the pilot experiment of the present study, inoculation of a 10 -1 dilution of the GSDIV stock into experimental fish resulted in ca. 60% mortality and was determined to be the appropriate dilution for the vacci-nation trials. In the vaccination trials, as expected, mortality in the unvaccinated group began 8 d after challenge with GSDIV, reaching plateaus of 59.3 and 66.7% in the duplicate tanks within 13 d. In contrast, 0 mortality occurred in the vaccinated fish. Diseased fish usually displayed loss of appetite and sleepy behavior indicated by lying on a pectoral fin and subsequently lying on their side just before death. All moribund fish displayed a slight dark coloration of the body surface and a markedly swollen spleen. The surviving fish in the unvaccinated group and vaccinated group did not display sleepy behavior and maintained a good appetite throughout the experimental period.
Of the surviving, vaccinated fish (a total of 27), histopathology was mainly observed in the spleen. Multiple cellular masses comprised of increased numbers of enlarged cells, many of which contained brown-colored hemosiderin pigmentation, and a few others had a pale cytoplasm (Table 1, Fig. 1a) . The same masses of enlarged cells were also found in the hematopoietic tissue of the kidney. No histopathology was observed in the gill, liver, heart or digestive tracts.
Of the 26 moribund fish in the unvaccinated group, all spleens contained many IBCs as well as necrotized cells with large numbers of GSDIV virions within the splenic pulps and ellipsoids (Table 1, Fig. 1b ). In the kidney many IBCs appeared in the hematopoietic tissues. The gill, liver, heart and digestive tracts contained a few IBCs. In contrast, the spleen and kidney of 16 surviving fish in the unvaccinated group exhibited large numbers of masses comprised of many enlarged cells with a pale cytoplasm, and a few other cells contained brown hemosiderin pigments (Table 1, Fig. 1c,d) the liver, but no masses of enlarged cells were found in the gill, heart or digestive tracts. Electron microscopic (EM) examination of the spleen of surviving fish in the vaccinated group revealed enlarged cells and cells containing hemosiderin granules comprising electron-dense iron granules within the cytoplasm. The amount of deposited hemosiderin varied in the cells, some of which also contained melanin granules (Fig. 2) . In the cells containing a large amount of hemosiderin, the cytoplasm was mostly filled with hemosiderin granules, and the remaining part of the cytoplasm contained a few mitochondria and rough endoplasmic reticulum (rER). Other hemosiderin-laden cells appeared and contained residual hemosiderin granules, fibrous structures, myelin-like structures and scattered iron granules (Fig. 2b) . Other enlarged cells formed an amorphous matrix with a few mitochondria and rER (Fig. 2c) . Some enlarged cells had unidentifiable structures with scattered iron granules (Fig. 2d) . Viral particles were not observed.
In the unvaccinated group, EM examination of the spleen of moribund fish revealed various IBCs, which were the same as those shown in our previous study (Mahardika et al. 2004 ). In addition, EM examination of the masses of enlarged cells in surviving fish revealed they had a vacuolated amorphous matrix and contained a small number of GSDIV virions, fibrous structures, myelin-like structures and masses of fine granules, while organelles such as mitochondria and rER were rare (Fig. 3a-c) . Assembled virions were round rather than hexagonal with an electron-dense core (Fig. 3d) . Some of the enlarged cells contained hemosiderin granules comprised of electron-dense iron granules within the cytoplasm.
A tissue filtrate of virus-infected fish is often used in infection experiments to determine viral pathogenicity and fish susceptibility to disease. In the present study, we used a spleen filtrate of GSDIV-infected fish for the challenge test because in vitro virus culture was not available. The viral inoculum prepared from grouper spleen contained megalocytivirus based on PCR assays using the primer set that were derived from a Pst I restriction fragment of RSIV genomic DNA (Kurita et al. 1998) . Sudthongkong et al. (2002b) have confirmed that GSDIV is the same isolate as RSIV based on homology of ATPase and major capsid protein (MCP) genes. Taking those data and the observed sleepy behavior, the causative megalocytivirus was confirmed to be GSDIV. Electron microscopy revealed virus particles present in IBCs of moribund fish and enlarged cells of surviving fish in the unvaccinated group. PCR amplicons of the predicted size were derived from the DNA extracts of the spleens of 10 moribund fish and 10 surviving fish from the unvaccinated group, indicating they were virions of GSDIV. On the other hand, PCR products were not obtained from the 10 surviving fish that were examined from the vaccinated group. The formalininactivated RSIV vaccine has been shown previously to confer high levels of protection against RSIV disease in red sea bream Pagrus major (Nakajima et al. 1997) , yellowtail Seriola quinqueradiata, amberjack S. dumerili, kelp grouper Epinephelus moara, striped jack Pseudocaranx dentex and spotted parrot fish Oplegnathus punctatus under laboratory conditions . Moreover, it has been shown that vaccination of fish with an RSIV vaccine triggers a specific immune response as indicated by an enhanced expression of major histocompatibility complex (MHC) class I and increased levels of serum neutralization antibodies (Caipang et al. 2006) . The results from our present study confirmed that the RSIV vaccine was effective against GSDIV infection in humpback grouper, resulting in no mortality in the vaccinated group. 
